Curis, Inc. to Present at Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today announced that the Company will be presenting at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference, being held May 14-15, 2007 at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Curis’ presentation will take place on Tuesday, May 15, 2007 at 3:35 p.m. local time (9:35 a.m. Eastern Daylight Time).

MORE ON THIS TOPIC